Home > Research > Publications & Outputs > Intravenous lignocaine in the management of pri...
View graph of relations

Intravenous lignocaine in the management of primary fibromyalgia syndrome.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published
<mark>Journal publication date</mark>1995
<mark>Journal</mark>International Journal of Clinical Pharmacology Research
Issue number3
Volume15
Number of pages5
Pages (from-to)115-119
Publication StatusPublished
<mark>Original language</mark>English

Abstract

Ten patients with primary fibromyalgia syndrome were treated with intravenous infusions of lignocaine on a daily basis for six days. This treatment produced a clinically useful improvement in pain relief and mood scores at the time of discharge on day seven and at follow-up on day thirty.